{"id":"NCT03237481","sponsor":"Heron Therapeutics","briefTitle":"Phase 3 Herniorrhaphy Study for Postoperative Analgesia (EPOCH 2)","officialTitle":"A Phase 3, Randomized, Double Blind, Saline Placebo and Active Controlled, Multicenter Study of HTX 011 Via Local Administration for Postoperative Analgesia and Decreased Opioid Use Following Unilateral Open Inguinal Herniorrhaphy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-07-31","primaryCompletion":"2017-12-22","completion":"2018-01-16","firstPosted":"2017-08-02","resultsPosted":"2021-10-27","lastUpdate":"2025-03-07"},"enrollment":418,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"PREVENTION"},"conditions":["Postoperative Pain"],"interventions":[{"type":"DRUG","name":"HTX-011","otherNames":[]},{"type":"DRUG","name":"Bupivacaine HCl","otherNames":[]},{"type":"DRUG","name":"Saline placebo","otherNames":[]},{"type":"DEVICE","name":"Luer-lock applicator","otherNames":[]},{"type":"DEVICE","name":"Vial access device","otherNames":[]}],"arms":[{"label":"Treatment Group 1: HTX-011","type":"EXPERIMENTAL"},{"label":"Treatment Group 2: Bupivacaine HCI","type":"ACTIVE_COMPARATOR"},{"label":"Treatment Group 3: Saline Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This is a Phase 3, randomized, double-blind, saline placebo- and active-controlled, multicenter study to evaluate the analgesic efficacy and safety of HTX 011 administered via local administration into the surgical site in subjects undergoing unilateral open inguinal herniorrhaphy.","primaryOutcome":{"measure":"Mean Area Under the Curve (AUC) of the Numeric Rating Scale (NRS) Pain Intensity Scores With Activity (NRS-A) Through 72 Hours Postsurgery (AUC0-72), Compared With Saline Placebo.","timeFrame":"72 hours","effectByArm":[{"arm":"Treatment Group 1: HTX-011","deltaMin":269.39,"sd":173.719},{"arm":"Treatment Group 3: Saline Placebo","deltaMin":350.82,"sd":171.224}],"pValues":[{"comp":"OG000 vs OG001","p":"= 0.0004"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":18},"locations":{"siteCount":24,"countries":["United States","Belgium"]},"refs":{"pmids":["34318438","34284613"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":163},"commonTop":["Nausea","Constipation","Dizziness","Headache","Dysgeusia"]}}